# INCASSIA
> **ANDA207304** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2016-09-23
## Drug
- **FDA Application Number:** ANDA207304
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** INCASSIA
- **Generic name:** NORETHINDRONE
- **Active ingredients:** NORETHINDRONE
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Afaxys Pharma, LLC
- **First approval:** 2016-09-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207304)
---
*MORVS · CC0 1.0*